Compile Data Set for Download or QSAR
maximum 50k data
Found 101 of ic50 data for polymerid = 5662
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103446(US8552037, 93)
Affinity DataIC50:  0.0490nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103448(US8552037, 95)
Affinity DataIC50:  0.0910nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103450(US8552037, 98)
Affinity DataIC50:  0.120nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103443(US8552037, 90)
Affinity DataIC50:  0.130nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103456(US8552037, 123)
Affinity DataIC50:  0.140nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103438(US8552037, 83)
Affinity DataIC50:  0.220nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103440(US8552037, 86)
Affinity DataIC50:  0.220nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103437(US8552037, 82)
Affinity DataIC50:  0.240nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103454(US8552037, 116)
Affinity DataIC50:  0.280nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103445(US8552037, 92)
Affinity DataIC50:  0.280nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103449(US8552037, 97)
Affinity DataIC50:  0.280nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM9019(CHEMBL45 | Melatonin | N-[2-(5-methoxy-1H-indol-3-...)
Affinity DataIC50:  0.300nMAssay Description:In vitro receptor binding at MT2 (Melatonin) receptor.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMedDrugBank

TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103441(US8552037, 87)
Affinity DataIC50:  0.310nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103442(US8552037, 89)
Affinity DataIC50:  0.310nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103436(US8552037, 81)
Affinity DataIC50:  0.370nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103452(US8552037, 100)
Affinity DataIC50:  0.410nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103439(US8552037, 84)
Affinity DataIC50:  0.430nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM9019(CHEMBL45 | Melatonin | N-[2-(5-methoxy-1H-indol-3-...)
Affinity DataIC50:  0.530nMAssay Description:Binding affinity to human MT2 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMedDrugBank

TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM9019(CHEMBL45 | Melatonin | N-[2-(5-methoxy-1H-indol-3-...)
Affinity DataIC50:  0.530nMAssay Description:Displacement of 2-[125I]iodomelatonin from human MT2 receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMedDrugBank

TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50037242(CHEMBL323332 | N-(2-(5-methoxybenzofuran-3-yl)ethy...)
Affinity DataIC50:  0.700nMAssay Description:Displacement of 2-[125I]iodomelatonin from human MT2 receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103453(US8552037, 107)
Affinity DataIC50:  0.75nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103455(US8552037, 121)
Affinity DataIC50:  0.770nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50342770(CHEMBL456727 | N-(2-(7-(methylthio)naphthalen-1-yl...)
Affinity DataIC50:  0.955nMAssay Description:Binding affinity to human MT2 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50125645(1-[4-((R)-6-Methoxy-indan-1-yl)-piperazin-1-yl]-2-...)
Affinity DataIC50:  1.5nMAssay Description:In vitro receptor binding at MT2 (Melatonin) receptor.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50125647(1-[4-(6-Methoxy-indan-1-yl)-piperazin-1-yl]-2-meth...)
Affinity DataIC50:  1.5nMAssay Description:In vitro receptor binding at MT2 (Melatonin) receptor.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50125634(CHEMBL19653 | Cyclopropyl-[4-((R)-6-methoxy-indan-...)
Affinity DataIC50:  1.60nMAssay Description:In vitro receptor binding at MT2 (Melatonin) receptor.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50125644(4-((R)-6-Methoxy-indan-1-yl)-piperazine-1-carboxyl...)
Affinity DataIC50:  1.70nMAssay Description:In vitro receptor binding at MT2 (Melatonin) receptor.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50125633(1-[4-(6-Methoxy-indan-1-yl)-piperazin-1-yl]-butan-...)
Affinity DataIC50:  2.30nMAssay Description:In vitro receptor binding at MT2 (Melatonin) receptor.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50125639(CHEMBL19339 | Cyclopropyl-[4-(6-methoxy-indan-1-yl...)
Affinity DataIC50:  3nMAssay Description:In vitro receptor binding at MT2 (Melatonin) receptor.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50125649(4-(6-Methoxy-indan-1-yl)-piperazine-1-carboxylic a...)
Affinity DataIC50:  3.10nMAssay Description:In vitro receptor binding at MT2 (Melatonin) receptor.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50155742(1-[1-(2,2-Diphenyl-ethyl)-7-methoxy-3,4-dihydro-1H...)
Affinity DataIC50:  5.5nMAssay Description:Inhibitory concentration against Melatonin receptor type 1BMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103447(US8552037, 94)
Affinity DataIC50:  6.20nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50011340(CHEMBL3260981)
Affinity DataIC50:  6.70nMAssay Description:Binding affinity to MT2 receptor (unknown origin) expressed in HEK293 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103451(US8552037, 99)
Affinity DataIC50:  8.5nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM103444(US8552037, 91)
Affinity DataIC50:  9.60nMAssay Description:Binding assay using melatonin receptors 1 or 2.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50155730(1-[1-(2,2-Diphenyl-ethyl)-6,7-dimethoxy-3,4-dihydr...)
Affinity DataIC50:  9.70nMAssay Description:Antagonist activity at MT2 receptor (unknown origin) assessed as cAMP accumulationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50155730(1-[1-(2,2-Diphenyl-ethyl)-6,7-dimethoxy-3,4-dihydr...)
Affinity DataIC50:  9.70nMAssay Description:Inhibitory concentration against Melatonin receptor type 1BMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50155721(1-(2,2-Diphenyl-ethyl)-6,7-dimethoxy-3,4-dihydro-1...)
Affinity DataIC50:  9.90nMAssay Description:Inhibitory concentration against Melatonin receptor type 1BMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50155726(1-(2,2-Diphenyl-ethyl)-6,7-dimethoxy-3,4-dihydro-1...)
Affinity DataIC50:  22nMAssay Description:Inhibitory concentration against Melatonin receptor type 1BMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50155744(CHEMBL365648 | Cyclobutyl-(6,7-dimethoxy-1-pheneth...)
Affinity DataIC50:  24nMAssay Description:Inhibitory concentration against Melatonin receptor type 1BMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50155716(1-[6-Bromo-1-(2,2-diphenyl-ethyl)-7-methoxy-3,4-di...)
Affinity DataIC50:  24nMAssay Description:Inhibitory concentration against Melatonin receptor type 1BMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50342769(CHEMBL1770214 | N-[2-(7-methoxycarbonylamino-napht...)
Affinity DataIC50:  26nMAssay Description:Binding affinity to human MT2 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50155718(1-(2,2-Diphenyl-ethyl)-6,7-dimethoxy-3,4-dihydro-1...)
Affinity DataIC50:  30nMAssay Description:Inhibitory concentration against Melatonin receptor type 1BMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50125636(1-[4-(6-Methoxy-indan-1-yl)-piperazin-1-yl]-propan...)
Affinity DataIC50:  32nMAssay Description:In vitro receptor binding at MT2 (Melatonin) receptor.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50125638(1-[4-(6-Methoxy-indan-1-yl)-piperazin-1-yl]-ethano...)
Affinity DataIC50:  44nMAssay Description:In vitro receptor binding at MT2 (Melatonin) receptor.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50155734(1-[1-(2,2-Diphenyl-ethyl)-6,8-dimethoxy-3,4-dihydr...)
Affinity DataIC50:  45nMAssay Description:Inhibitory concentration against Melatonin receptor type 1BMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50155741(1-(2,2-Diphenyl-ethyl)-6,7-dimethoxy-3,4-dihydro-1...)
Affinity DataIC50:  60nMAssay Description:Inhibitory concentration against Melatonin receptor type 1BMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50155717(1-[1-(2,2-Diphenyl-ethyl)-6,7-dimethoxy-3,4-dihydr...)
Affinity DataIC50:  62nMAssay Description:Inhibitory concentration against Melatonin receptor type 1BMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50125642(CHEMBL275205 | Cyclopropyl-[4-(7-methoxy-1,2,3,4-t...)
Affinity DataIC50:  75nMAssay Description:In vitro receptor binding at MT2 (Melatonin) receptor.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMelatonin receptor type 1B(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM50155723(1-(6,7-Dimethoxy-1-phenethyl-3,4-dihydro-1H-isoqui...)
Affinity DataIC50:  76nMAssay Description:Antagonist activity at MT2 receptor (unknown origin) assessed as cAMP accumulationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 101 total ) | Next | Last >>
Jump to: